Dementia prevention, intervention, and care.
By G. Livingston, A. Sommerlad, V. Orgeta, Sergi G. Costafreda, Jonathan Huntley, D. Ames, C. Ballard, Sube Banerjee, A. Burns, J. Cohen-Mansfield and 14 more. The Lancet, 2017
4,936 citations recorded by the source corpus.
Subfields: General Health Professions, Psychiatry and Mental health, Sociology and Political Science
View Paper: https://www.semanticscholar.org/paper/4a2a3185ec72e8d5be71bbaf080efe521c23cb68
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Psychiatry and Mental health
Citations in the corpus
- Hearing Loss, Loneliness, and Social Isolation: A Systematic Review (2020, background): “In fact, a recent report identified hearing loss as the largest potentially modifiable risk factor for dementia, with a population attributable fraction of 9%.(17) Social isolation and loneliness are hypothesized potential mechanisms through which hearing loss may be associated with worsened cogniti”
- Early-Stage Alzheimer's Disease Prediction Using Machine Learning Models (2022, background): “Studies have suggested (6) that early intervention and treatment of modifiable Alzheimer’s risk factors can prevent or delay 30% of cases of Alzheimer’s (7).”
- Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 (2022, neutral): “49–51 Evidence suggests that hospitalisation rates are higher among those with dementia than among those without dementia, and health systems need to be prepared for the expected increases in service use that will accompany increases in the number of people with dementia.”
- Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019, positive): “Memantine is a uncompetitive NMDA receptor modulator that may act to inhibit glutamatemediated neurotoxicity that develops as neurons die during AD progression, although the precise mechanism of its effect is unclear (Greenamyre et al., 1988; Livingston et al., 2017).”
- Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020, neutral): “2,199,200 However, although available in most countries these drugs are no longer remunerated in France because it is felt that they offer only a small benefit while shifting clinician’s attention from other interventions.”